Showing results (21-30 of 616) with videos related to
Sort By:
Pageof 62
Clinical and Experimental Immunology|November 1, 1979
Monomeric (7S) IgM in chronic liver diseaseY M Fakunle, F Aranguibel, D de Villiers, et al.Liver|April 1, 1983
Incidence of hepatitis B virus infection in alcoholic liver disease, HBsAg negative chronic active liver disease and primary liver cell cancer in BritainM F Bassendine, L Della Seta, J Salmeron, et al.British Medical Journal|August 19, 1978
HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabineR G Chadwick, M F Bassendine, E M Crawford, et al.Gut|November 1, 1975
Antibodies to Escherichia coli in chronic liver diseasesA E Simjee, J M Hamilton-Miller, H C Thomas, et al.Scandinavian Journal of Gastroenterology|January 1, 1980
Viral antibody titres in HBs antigen-positive and -negative chronic active hepatitisF B Crimmins, D Adams, M Ross, et al.Clinical and Experimental Immunology|November 1, 1976
Peripheral blood lymphocyte populations in chronic liver diseaseH C Thomas, M Freni, J Sanchez-Tapias, et al.Gastroenterology|May 1, 1981
Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled studyM F Bassendine, R G Chadwick, J Salmeron, et al.Gastroenterology|July 1, 1980
Immune function in patients with extrahepatic portal venous obstruction and the effect of splenectomyL J Webb, M Ross, R L Markham, et al.Hepatology (Baltimore, Md.)|November 1, 1985
A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replicationA S Lok, D M Novick, P Karayiannis, et al.Gut|August 1, 1982
Effects of prednisolone/azathioprine in chronic hepatitis B viral infectionI V Weller, M F Bassendine, A K Murray, et al.Pageof 62